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A novel mode of enhancer evolution: The Tal1 stem
cell enhancer recruited a MIR element to specifically
boost its activity
Aileen M. Smith,1 Maria-Jose Sanchez,1,3 George A. Follows,1 Sarah Kinston,1
Ian J. Donaldson,2 Anthony R. Green,1,4 and Berthold Göttgens1,4,5
1University of Cambridge Department of Haematology, Cambridge Institute for Medical Research, Cambridge CB2 2XY,
United Kingdom; 2University of Manchester Faculty of Life Sciences, Manchester M13 9PT, United Kingdom
Altered cis-regulation is thought to underpin much of metazoan evolution, yet the underlying mechanisms remain
largely obscure. The stem cell leukemia TAL1 (also known as SCL) transcription factor is essential for the normal
development of blood stem cells and we have previously shown that the Tal1 +19 enhancer directs expression to
hematopoietic stem cells, hematopoietic progenitors, and to endothelium. Here we demonstrate that an adjacent
region 1 kb upstream (+18 element) is in an open chromatin configuration and carries active histone marks but does
not function as an enhancer in transgenic mice. Instead, it boosts activity of the +19 enhancer both in stable
transfection assays and during differentiation of embryonic stem (ES) cells carrying single-copy reporter constructs
targeted to the Hprt locus. The +18 element contains a mammalian interspersed repeat (MIR) which is essential for the
+18 function and which was transposed to the Tal1 locus ∼160 million years ago at the time of the mammalian/marsupial
branchpoint. Our data demonstrate a previously unrecognized mechanism whereby enhancer activity is modulated by a
transposon exerting a “booster” function which would go undetected by conventional transgenic approaches.
[Supplemental material is available online at www.genome.org.]
Increased biological complexity during evolution does not cor-
relate with gene number but rather with increasing complexity of
gene regulation (Levine and Tjian 2003). However, the evolution
of cis-regulatory mechanisms remains poorly understood. This is
largely due to the fact that, compared with coding sequences,
very little is known about the way in which regulatory informa-
tion is encoded in the genome. Developmental programs are
thought to be executed through transcriptional networks which
provide the capability to propagate transcriptional changes
through feed forward as well as positive and negative feedback
loops (Davidson 2006). Individual cis-regulatory elements are key
components of these transcription factor networks since they
function as information-processing units by integrating the in-
puts of their respective upstream regulators into tightly con-
trolled spatiotemporal expression patterns.
Repetitive DNA, largely derived from transposable elements,
is known to make up ∼50% of the human genome (Lander et al.
2001) and has historically been thought of as “junk” DNA. Fol-
lowing the recent completion of the opossum genome project, it
has become increasingly clear that transposable element-derived
DNA may play a larger role in gene regulation than previously
thought (Gentles et al. 2007). Several topical reports have high-
lighted that thousands of these elements are under strong puri-
fying selection and are therefore likely to have gained a beneficial
function that promotes host fitness (Kazazian 2004; Bejerano et
al. 2006; Xie et al. 2006). Indeed, it has been suggested that at
least 16% of eutherian-specific conserved noncoding elements
are derived from transposons and that these are commonly
found in the gene loci of key developmental genes, suggesting
that they play a role in controlling expression of these genes
(Mikkelsen et al. 2007). To date, very few of these elements have
been functionally validated. However, there have been specific
instances where repetitive elements have been shown to func-
tion as silencers (Donnelly et al. 1999) and polyadenylation or
alternative splice sites (Medstrand et al. 2005), although experi-
mental validation has so far been largely restricted to those ele-
ments derived from the more recent, primate-specific Alu family
of repeats. However, a role for more ancient repeats in gene regu-
lation is also now emerging with the discovery of two neuronal
enhancers that are derived from ancient short interspersed
nucleotide elements (SINE) retroposons (Bejerano et al. 2006;
Santangelo et al. 2007).
Hematopoietic stem cell (HSC) specification and subsequent
differentiation into the many mature blood lineages is one of the
best-understood vertebrate developmental systems. The stem cell
leukemia (SCL) transcription factor, also known as TAL1, is es-
sential for the specification of HSC and the development of he-
matopoiesis (Porcher et al. 1996; Robb et al. 1996). As part of a
systematic analysis of the transcriptional mechanisms regulating
the Tal1 locus, we have identified multiple cell type-specific en-
hancers, each of which directs expression to a subdomain of the
overall Tal1 expression pattern (Gottgens et al. 1997; Sanchez et
al. 1999; Sinclair et al. 1999; Gottgens et al. 2000, 2001; Sanchez
et al. 2001; Gottgens et al. 2002a,b, 2004; Delabesse et al. 2005;
Silberstein et al. 2005; Ogilvy et al. 2007). The Tal1 +19 enhancer
lies 19 kb downstream from the first exon of Tal1 and directs
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expression to hemangioblasts, HSCs, hematopoietic progenitors,
and endothelium (Sanchez et al. 1999; Gottgens et al. 2002b).
Activity of this element is dependent on two conserved Ets and
one conserved GATA binding site. We have also developed bio
informatic tools to identify functionally related regulatory en-
hancers situated in the Fli1, Hhex (also known as Hex), and Smad6
gene loci (Donaldson et al. 2005a,b; Donaldson and Gottgens
2006; Pimanda et al. 2007a), and are thus beginning to define key
components of the transcriptional networks controlling HSCs
(Pimanda et al. 2007a,b).
In this paper we demonstrate that activity of the +19 en-
hancer is modulated by a novel “booster” element created by the
insertion of a mammalian interspersed repeat (MIR) transposon
∼160 million years ago.
Results
Chromatin structure of the mouse Tal1 stem cell enhancer
Our previous analysis of the regulation of the murine Tal1 gene
identified a 5.5-kb fragment 3 to the Tal1 coding region in which
we mapped the approximate positions of two regions of DNase I
hypersensitivity (+18 and +19 regions; nomenclature reflects the
approximate distance in kilobases from the beginning of exon 1;
Gottgens et al. 1997). Transgenic analysis showed that this frag-
ment directed expression of a lacZ reporter gene to endothelium
and blood progenitors throughout ontogeny (Sanchez et al.
1999) as well as to the vast majority of long term repopulating
HSCs from fetal liver and adult bone marrow (Sanchez et al.
2001). Subsequent transgenic studies demonstrated that a 640-bp
fragment containing the +19 hypersensitive site was sufficient to
drive reporter gene expression in embryonic tissues (Gottgens et
al. 2002a) but was prone to being silenced in adult tissues (Sil-
berstein et al. 2005). The function of the +18 remained obscure.
To assess the potential significance of the +18 region we first
performed comparative sequence analysis of the intergenic seg-
ment between Tal1 and Pdzk1ip1. This analysis demonstrated
that, in addition to the previously described +19 and +23 en-
hancers (Gottgens et al. 2000), the region at +18 was also con-
served between mouse and human (Fig. 1A). Real-time PCR map-
ping (Follows et al. 2007) was used to confirm the presence of a
DNase I-hypersensitive site in the +18 region of the myeloid pro-
genitor cell line 416B (Fig. 1B; Dexter et al. 1979). The location of
the hypersensitive site was further refined using a restriction en-
donuclease accessibility assay with a resolution of ∼100 bp (Gott-
gens et al. 2001) and was found to correspond precisely with the
+18 peak of sequence homology (Fig. 1C). Chromatin immuno-
precipitation (ChIP) analysis of 416B cells demonstrated clear
binding of GATA2 to the +19 region, confirming our previous
results (Gottgens et al. 2002b), but little binding to the +18 re-
gion (Fig. 1B). In contrast, histone H3K9 acetylation was more
prominent over the +18 region compared to the +19 region (Fig.
1B). Taken together these results demonstrate that the +18 region
is conserved and contains a DNase I-hypersensitive site together
with acetylation of H3K9, all features of a cis-regulatory element.
The +18 region does not function as a classical enhancer
While analysis of regulatory elements in cell lines is relatively
high throughput and cost effective, only in vivo analysis using
transgenic animals can identify true in vivo enhancer activity
across different tissues. We generated lacZ reporter constructs
containing the +18 region (460-bp fragment), the +19 region
(640-bp fragment), or both (1.1-kb fragment) together with the
SV40 minimal promoter (Fig. 2A). These constructs were used to
create transgenic embryos which were analyzed at mid-gestation
by staining for -galactosidase activity. The +19 and the +18,19
constructs both gave rise to strong hematopoietic and endothe-
lial staining in 5/7 and 2/2 transgenic embryos, respectively (Fig.
2B; Table 1). In contrast, this pattern was absent in all transgenic
embryos carrying the +18 construct (n = 21) and in all those with
the construct containing the SV40 minimal promoter alone
(n = 9) (Fig. 2B; Table 1). Although all four Tal1 enhancers
Figure 1. Identification of the + 18 region as a region of open chro-
matin. (A) Sequence homology plot between mouse and human high-
lighting the +19 and +23 elements with known regulatory functions and
the conserved peak at +18. Numbering corresponds to distances in kilo-
bases from the start of exon 1a with the exons shown as black boxes and
the repeat regions marked in gray. (B) Chromatin status and transcription
factor occupancy in the Tal1 3 flanking region. DNase I/ChIP assays were
performed in the 416B cell line with either DNase I (black bars), AcK9
(gray bars), or GATA2 (white bars) and analyzed by real-time PCR using
primers across a 4-kb segment of the Tal1 locus from +17 to +20. The
levels of enrichment were normalized to untreated DNase I control or to
IgG and plotted as fold increase over the +20 control region. (C) Restric-
tion endonuclease accessibility assay showing the mapping of the +18
hypersensitive site (arrowhead). Nuclei were incubated with increasing
concentrations of PalI and the extracted DNA digested with HindIII.
Southern blot analysis was performed with the indicated probe.
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described so far are able to function with the SV40 promoter
(Sanchez et al. 1999; Sinclair et al. 1999; Gottgens et al. 2000,
2002b, 2004; Delabesse et al. 2005), we considered the possibility
that the +18 element may be unable to interact with this pro-
moter and may require the endogenous Tal1 promoter. We
therefore generated constructs carrying the Tal1 promoter region
with and without the +18 element. As previously described, a
3.8-kb Tal1 promoter fragment directs expression to the mid-
brain and spinal cord (Sinclair et al. 1999). However, inclusion of
the +18 element did not result in any additional activity (Fig. 2B;
Table 1). Taken together these data demonstrate that the +18
region does not show any enhancer activity in transgenic mouse
embryos at mid-gestation, a time point when all organ systems
are already developing.
The +18 region can boost the activity of the +19 enhancer
in stable transfection assays
Having established that the +18 region did not function as an
independent enhancer, we next asked whether it might be able
to modulate activity of the +19 enhancer. Consistent with our
transgenic results a luciferase reporter construct containing the
+18 element on its own was inactive in stable transfection ex-
periments using 416B cells (Fig. 2C). In contrast, the + 19 en-
hancer generated a 15-fold increase in luciferase activity com-
pared to a construct containing the SV40 promoter alone. Inclu-
sion of the +18 element as well as the +19 enhancer reliably
produced a further twofold increase in luciferase activity. These
results therefore suggested that the +18 region may have a role in
boosting the activity of the +19 enhancer, which is consistent
with our observation that deletion of the +18 region from a
2.5-kb Tal1 3 enhancer fragment results in a 50% reduction of
enhancer activity in stable transfection assays (Supplemental
Fig. 1). The activity of the +18 region was further assessed using
a beta-geo reporter cassette in stable transfection assays using
cotransfection of a puromycin marker for stable selection. Pools
of stably transfected clones were analyzed after 3-wk selection in
puromycin by flow cytometry. Cells containing the combined
+18 and +19 elements showed a fourfold higher mean fluores-
cence than cells containing the +19 alone (Supplemental Fig. 2),
demonstrating that the +18 region increases the transcriptional ac-
tivity of the +19 enhancer when stably integrated into chromatin.
Single-copy analysis of +18 function during embryonic stem
(ES) cell differentiation
The interpretation of stable transfection experiments is compli-
cated by the fact that the reporter constructs are usually inte-
grated as multiple concatenated copies and are also subject to
position effects. Furthermore, transformed cell lines are unlikely
to provide a normal transcriptional environment. To circumvent
these issues, we used a gene targeting method that allows single-
copy transgenes to be inserted upstream of the X-linked Hprt1
gene (Bronson et al. 1996; Misra et al. 2001) in HM-1 ES cells.
This male ES cell line carries an inactivating deletion of the pro-
moter and exons 1 and 2 of the Hprt1 gene. Upon successful
Table 1. Activity of Tal1 regulatory elements in transgenic
embryos
Construct
No. of
transgenic
embryos
Expression
Blood/endothelium Midbrain Ectopic
SV/Lac 9 0 0 4
SV/Lac/+18 21 0 0 4
SV/Lac/+19 7 5 0 0
SV/Lac/+18,19 2 2 0 0
0.9E3/Lac 8 0 6 4
0.9E3/Lac/+18 5 0 5 1
F0 transgenic embryos were generated using the constructs shown on the
left and collected at embryonic days 11–12.5 followed by overnight stain-
ing with X-gal to determine lacZ activity. lacZ expression patterns for
each of the constructs are shown on the right.
Figure 2. The +18 region does not behave as a classical enhancer. (A)
Schematic of the Tal1 locus indicating the positions of the 0.9E3 Tal1
promoter, +18 and +19 regions. (B) Whole-mount staining of mid-
gestation transgenic embryos expressing lacZ under the control of either
the SV40 minimal promoter or the 0.9E3 Tal1 promoter with and without
the +18, the +19, or the +18/+19 elements combined. (C) The +18 region
boosts the activity of the Tal1 +19 enhancer in 416B stable transfection
assays. Shown on the left are the reporter constructs of the +18 element,
the 640-bp +19 element, and the 1.1-kb +18/+19 fragment inserted
downstream from the SV40 luciferase reporter cassette. The results are
shown on the right with the luciferase values presented as fold increase
over the SV40 luciferase control, which was assigned a value of 1.
Smith et al.
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homologous recombination with an exogenous Hprt1 targeting
vector, the functional activity of Hprt1 is restored, permitting
selection of correctly targeted clones in HAT media. Targeting
vectors were generated using three different lacZ reporter con-
structs: SV40 minimal promoter alone; the promoter with the
+19 enhancer; the promoter with the +19 enhancer and the +18
element (Fig. 3A). Each targeting vector was used to generate ES
cell lines carrying a single copy of the appropriate reporter con-
struct targeted to the Hprt locus. Activity of the reporter con-
structs was then assessed during ES cell differentiation.
Several groups have shown that Tal1 switches on around
day 2.5 of ES cell differentiation and that this expression coin-
cides with the onset of hemangioblast specification (Elefanty et
al. 1997; Fehling et al. 2003). Prior to plating in differentiation
assays, X-gal was used to stain each of the ES cell lines targeted
with SV/Lac, SV/Lac/+19, and SV/Lac/+18,19. As would be ex-
pected no staining was observed in any of the targeted cell lines
(Fig. 3B).
Embryoid bodies (EBs) were then generated from each of the
targeted ES cell lines and lacZ activity assessed at day 3 and day
8 of differentiation (Fig. 3B). No staining was observed in EBs
with the SV40 lacZ control vector at either day of differentiation.
X-gal staining of EBs carrying the +19 enhancer alone (SV/Lac/
+19) showed high levels of lacZ expression in day 3 EBs, which
markedly decreased by day 8 of differentiation. In striking con-
trast, EBs containing both +18 and +19 regions (SV/Lac/+18,19)
showed high levels of lacZ activity observed by X-gal staining at
both days 3 and 8 of differentiation. lacZ activity in EBs was also
quantified using a colorimetric assay. In cells carrying SV/Lac/
+19 alone, the mean lacZ activity per 1  106 cells showed a
twofold reduction in lacZ activity between days 3 and 8 of dif-
ferentiation whereas cells containing SV/Lac/+18,19 showed a
fourfold increase (Supplemental Fig. 3). These data demonstrate
that, during hematopoietic differentiation of ES cells, a single
copy of the +18 element boosts activity of an adjacent +19 stem
cell enhancer by almost an order of magnitude.
Functional activity of the +18 region resides in a mammalian
interspersed repeat
To investigate the +18 region more closely, we focused on the
sequence conservation plot between mouse and human (Fig. 1A),
which showed several blocks of se-
quence identity. To our surprise, these
coincided with a stretch of 211 bp
masked as repetitive sequence in the
UCSC and Ensembl genome browsers.
To determine the nature of the repeat,
we screened the DNA sequence of the
+18 region with the RepeatMasker pro-
gram (A.F.A. Smit, R. Hubley, and P.
Green, 1996–2004. RepeatMasker Open-
3.0; http://www.repeatmasker.org),
which identified the +18 repeat as a
member of the mammalian interspersed
repeat (MIR) family (Fig. 4A; Smit and
Riggs 1995). In stable transfection assays
using 416B cells (Fig. 4B), a 1.1-kb frag-
ment containing both +18 and +19 ele-
ments produced a 90-fold increase in lu-
ciferase activity relative to a construct
containing the SV40 promoter alone.
Deletion of 460 bp containing the +18
element halved activity of the construct.
A similar effect was observed following
deletion of the 200 bp containing the
MIR repeat.
In vivo DMS footprinting was per-
formed to search for DNA sequence mo-
tifs that might mediate the boosting ef-
fect of the +18 region. No footprints
were observed in the 400-bp +18 region
apart from the protection of three bases
(Fig. 4C, open circles) around the first
block of sequence conservation (M1, Fig.
4A) situated between the MIR A and B
box sequences. We therefore generated a
construct whereby we mutated the M1
region to a BglII restriction site and as-
sessed its activity in our 416B assay.
Analysis of the mutant construct, SV/Luc/
+18,19M1, also showed a decrease in lu-
ciferase activity comparable to the SV/
Figure 3. The +18 region can boost the activity of the Tal1 +19 stem cell enhancer. (A) Schematic
representation of the Hprt locus in the HM-1 ES cell line, which carries a deletion of exons 1 and 2. SV40
lacZ reporter constructs with or without the 1.1-kb +18/+19 fragment or the +19 element were cloned
into an Hprt targeting vector containing the promoter and exon 1 of the human HPRT locus and 2.9
kb of the mouse genomic locus including exon 2. The targeted Hprt locus contains the SV40 lacZ
reporter cassettes integrated upstream of the promoter of the fully functional Hprt locus. (B) ES cells
expressing either the SVLac control, SVLac/+19, or SVLac/+18,+19 were plated into differentiation
assays and analyzed at days 0, 3, and 8 of differentiation. lacZ activity was assessed by staining with
X-gal for 2 h.
Evolution of a stem cell enhancer
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Luc/+18,19MIR construct (Fig. 4C). Bio-
informatic analysis of the conserved motif
M1 using the TRES web server (TRES: com-
parative promoter sequence analysis; Katti
et al. 2000) showed that this conserved
motif did not match any of the 222
TRANSFAC consensus binding site posi-
tional weight matrices or any of the 5919
experimentally characterized sites present
in the TRES database. We also used the
recently described software tool STAMP,
which is specifically designed to predict
the identity or structural class of proteins
binding to a given sequence motif (Ma-
hony et al. 2007). Using the JASPAR and
TRANSFAC data sets, STAMP also failed to
identify any match to the motif M1.
Taken together these results indicate that
the boosting effect of the +18 region is
mediated by sequence derived from a MIR
repeat and that much of this activity de-
pends on the conserved sequence that lies
within the tRNA promoter-like domain of
this repeat element.
To determine whether the boosting
activity of the +18 region is nonspecific
or restricted to a subset of enhancers, we
inserted the 460-bp +18 element up-
stream of an SV40 enhancer and also a
Lyl1 promoter/enhancer element (Lyl1)
that we have previously shown to con
tain an Ets/Ets/GATA motif related to the
Tal1 +19 enhancer (Chan et al. 2007).
Both the SV/luc/SVEnh and SV/luc/Lyl1P
constructs are highly active in stable
transfection assays in 416B cells com-
pared to the SV40 promoter alone (data
not shown). When inserted into these
two constructs, the +18 region failed to
increase activity of the SV40 enhancer
any further but dramatically boosted the
activity of the Lyl1 element (Fig. 4D).
These results demonstrate that the +18
element is able to increase the activity of
two functionally related hematopoietic/
endothelial enhancers (Tal1 +19 and
Lyl1), but that it does not act nonspecif-
ically on all enhancers. The question as
to whether the activity of other enhanc-
ers may be modulated in a similar way
to the Tal1 +18/+19 interaction will re-
quire comprehensive analysis using the
multiple assays carried out here. How-
ever, we have noted that another hema-
topoietic enhancer (Fli+12; Donaldson
et al. 2005b) is situated <1 kb down-
stream from an exapted MER repeat.
Moreover, stable transfection assays sug-
gest that this repeat region is also ca-
pable of functioning as a positive modu-
lator enhancer activity (see Supplemen-
tal Fig. 4).
Figure 4. A MIR repeat within the +18 region boosts the activity of the Tal1 +19 enhancer. (A)
Mouse/human nucleotide sequence of the +18 region aligned to the MIR consensus sequence, in
which the A and B boxes of the MIR tRNA region are underlined. The nucleotide sequence contained
within the boxed region denotes the 200 bp of the +18 region that was deleted in the SV/Luc/
+18,19MIR construct, and the conserved sequence that was mutated to a BglII restriction site for
SV/Luc/+18,19M1 is marked. (B) Mutation analysis of the +18 region. Shown on the left are the
luciferase reporter constructs depicting the deletion in the +18 region and the mutation in the first
block of sequence conservation highlighted in A. The mutation constructs were analyzed in 416B stable
transfection assay and the luciferase values presented as fold increase over the SV40 luciferase control,
which was assigned a value of 1. Data are presented as the mean luciferase activity of three biological
replicates performed in quadruplicate plus or minus the standard error of the mean. (C) In vivo DMS
footprinting of the +18 MIR repeat region (antisense strand). Protections () were observed over the
M1 region of the MIR repeat in two independent 416B samples compared to the naked genomic
control. (D) Shown on the left are the luciferase reporter with constructs, either the heterologous SV40
enhancer or the tissue-specific Lyl1 promoter proximal enhancer, inserted downstream from the SV40
luciferase reporter cassette with and without the +18 region. The luciferase activities are shown as fold
increase over SV40 luciferase with either the SV40 enhancer or the Lyl1 enhancer, each of which was
assigned a value of 1.
Smith et al.
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This led us to examine if the presence of MIR repeats within
close proximity to cis-regulatory regions might be a more wide-
spread phenomenon. To this end, we considered 2768 lymphoid
DNase I-hypersensitive sites that have been mapped as part of the
ENCODE project (Sabo et al. 2004). As a control, we performed
the same analysis on 1000 sets of 2768 randomly chosen geno-
mic coordinates to determine a normal distribution, allowing us
to assign z-scores to any subsequent results. On average, we
found 20% of randomly chosen coordinates have MIR repeats
within 500 bp. In contrast, when we analyzed the 2768 lymphoid
DNase I-hypersensitive sites, we found that 26% have a MIR re-
peat within 500 bp (Z-score 7.65 when compared to random
genomic coordinates). MIR repeats had previously been reported
to be evenly distributed with respect to the location of coding
genes (Medstrand et al. 2002). Given the recent availability of
data sets containing genome-wide patterns of histone modifica-
tions (Barski et al. 2007), we chose to further investigate the
distribution pattern of MIR repeats (see Methods). We found that
36% of H3K4me1 sites, 23% of H3K4me3 sites, and 28% of
H3K27me3 sites contain a MIR within 500 bp, suggesting that
MIR repeat distribution throughout the genome is not random
with the prevalence of MIR repeats next to H3K4me1 sites being
particularly striking. Finally, we interrogated a recent genome-
wide data set of DNase I-hypersensitive sites in human CD4 T-cells
which reported fairly precise regions of hypersensitivity (Boyle et al.
2008). Out of the 95,723 DNase I-hypersensitive sites reported in
the paper, 19% overlap with sequence annotated as MIR repeat
compared to 12% of 95,723 randomly chosen regions of the same
length as the 95,723 DNase I-hypersensitive regions. Taken to-
gether, the above analyses therefore indicated that MIR repeats
may be enriched near regulatory regions consistent with a more
widespread role in cis-regulation.
Sequential evolution of the Tal1 stem cell enhancer
Our observation that the +18 region was derived from a MIR
repeat suggested that it evolved from a transposition event some-
time during early mammalian evolution. To investigate the tim-
ing of this transposition, we obtained genomic sequences of the
Tal1 locus for 10 mammals and also chicken as an outgroup for
comparative analysis. Mouse, human, dog, platypus, and chicken
sequences were obtained from BAC clones isolated by us pre-
viously and sequenced by the Wellcome Trust Sanger Institute
(Gottgens et al. 2000, 2002a), while the remaining sequences
were downloaded from the Ensembl genome browser. The 11
sequences were aligned using seven different alignment pro-
grams (ClustalW, MLagan, MAVID, Dialign, DialignT, TCoffee,
MUSCLE) to minimize the likelihood of
missing significant alignment blocks.
Our comparative sequence analysis
demonstrated that both the +18 and +19
elements were present in all eight euthe-
rian mammals that were analyzed (Fig.
5A; data not shown), but only the +19
could be detected in the more distantly
related opossum and platypus. To confirm
that our failure to detect homology with
the +18 region in platypus and opossum
was not a shortcoming of all seven align-
ment programs, we made use of the fact
that the eutherian +18 sequence is rec-
ognized as MIR-derived by the Repeat-
Masker program. No MIR repeats were
identified within 10 kb of the platypus
+19 sequence, and a MIR-derived se-
quence 600 bp upstream of the opossum
+19 element was inserted in the opposite
orientation to the MIR-derived euthe-
rian +18 region. Our results are therefore
consistent with a model where the +18
MIR element integrated next to the +19
enhancer at some point between the
marsupial branchpoint and the base of
extant eutherians (∼160 to 120 million
years ago), and was subsequently con-
served throughout the radiation of pla-
cental mammals (Fig. 5B).
Discussion
Transcriptional control is a key mecha-
nism controlling the formation and sub-
sequent behavior of blood stem cells.
Many transcription factors such as TAL1,
GATA2, ETV6 (also known as TEL), FLI1,
or RUNX1 are critical for the specifica-
Figure 5. Evolution of the Tal1 stem cell enhancer region. (A) Multiple species sequence alignment
of the +18 region detected in eight of the mammals analyzed. Mm, Mus musculus; Rn, Rattus norvegi-
cus; Hs, Homo sapiens; Bt, Bos taurus; Fc, Felis catus; Cf, Canis familiaris; La, Loxodonta africana; Ee,
Erinaceus europaeus. (B) Phylogentic tree depicting the divergence of the species listed on the right
(adapted from Murphy et al. 2007). Time window for the insertion of the Tal1 +18 region is indicated.
Md, Monodelphis domestica; Oa, Ornitorhynchus anatinus.
Evolution of a stem cell enhancer
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tion and/or subsequent development of HSCs. It is the combina-
torial activity of these (and additional as yet unknown) transcrip-
tion factors that characterizes the transcriptional environment of
HSCs, also termed the “regulatory state” (Davidson 2006). The
Tal1 +19 enhancer represents the best-characterized regulatory
element that specifically responds to the HSC regulatory state.
Using reporter genes, we have shown that the +19 enhancer di-
rects expression to HSCs in transgenic mice. The Tal1 enhancer
has also been used to generate mouse models for inducible trans-
gene expression, retroviral gene transfer, and Cre-mediated re-
combination as well as the development of acute myeloid leuke-
mia mouse models (Murphy et al. 2003; Eguchi et al. 2005;
Gothert et al. 2005; Koschmieder et al. 2005). At the molecular
level, activity of the +19 element critically depends on binding
sites for the Ets and GATA families of transcription factors and
this combination of transcription factors constitutes a regulatory
code employed by several other enhancers (Landry et al. 2005;
Pimanda et al. 2006, 2007a,b; Chan et al. 2007; Landry et al.
2008) that display similar expression patterns in transgenic as-
says.
Much less well understood are the mechanisms that control
quantitative aspects of gene expression, even though expression
levels of key regulators are critical both to the initial develop-
ment and maintenance of HSCs as well as their transformation
into malignant leukemia cells. For example, reducing the level of
key regulators can cause leukemia development, as illustrated by
the deletion of an upstream regulatory element of the mouse
PU.1 (also known as SFPI1) transcription factor, which results in
an 80% reduction of PU.1 expression without any gross alter-
ations to the overall expression pattern (Rosenbauer et al. 2004).
Interestingly, a single nucleotide polymorphism in the corre-
sponding human element reduces enhancer activity and is asso-
ciated with specific subtypes of human acute myeloid leukemia
(Steidl et al. 2007). Several possible mechanisms for this so-called
“dosing effect” of gene expression can be proposed: Firstly,
within a given regulatory element there may be binding sites that
mediate the quantitative effect. One such example seems to be
the PU.1 enhancer where the human SNP appears to affect bind-
ing of SATB1, which apparently plays no part in setting expres-
sion patterns but instead boosts the overall activity of the en-
hancer (Steidl et al. 2007). Alternatively, multiple tissue-specific
enhancers with overlapping expression patterns may be required
to act in an additive fashion, thus ensuring appropriate levels of
gene expression as seen for example in the -globin LCR (for
review, see Grosveld 1999). Here, we propose a third and novel
mechanism whereby domestication of transposable element-
derived DNA sequence functions in a quantitative manner to
boost the activity of a tissue-specific enhancer.
The new element (+18 region) is located 1 kb upstream of
the +19 Tal1 enhancer and can boost its activity, suggesting that
the Tal1 stem cell enhancer may encompass a larger gene regu-
latory domain. From our ES cell differentiation assays it appears
that the +18 region may contribute to the function of the Tal1
stem cell enhancer by maintaining expression of the +19 en-
hancer, and this may explain the lack of transgene expression in
adult mice when the +19 enhancer is used alone (Silberstein et al.
2005). Given that the +18 and +19 regions show the same tissue-
specific pattern of DNase I hypersensitivity, their physical prox-
imity, and specificity of enhancement, it is likely that they con-
stitute a regulatory unit within the Tal1 gene locus. The DNA
sequence in the +18 region is derived from an ancient MIR re-
peat. This family of repeats can be found in all mammalian or-
ders and is thought to have arisen more than 130 million years
ago (Jurka et al. 1995; Smit and Riggs 1995). MIR repeats consti-
tute ∼1%–2% of our DNA, initially characterized by a 70-bp core
sequence (Donehower et al. 1989) and more recently were shown
to be part of a longer 260-bp tRNA-derived SINE (Jurka et al.
1995; Smit and Riggs 1995; Gilbert and Labuda 1999).
When the MIR-derived +18 region was assayed in standard
classical enhancer assays, it failed to show any activity and there-
fore may easily have been disregarded when screening for regu-
latory elements. However, when tested upstream of hematopoi-
etic enhancers, it behaved in a quantitative manner to boost the
activity of these elements. We considered the possibility that the
function of the +18 region was related to boundary elements or
insulators. These latter elements are thought to play key roles in
organizing higher order chromatin structure and can serve to
protect a given gene locus from repressing influences of neigh-
boring regions of heterochromatin. At the molecular level, insu-
lator/boundary elements are characterized by the presence of
ubiquitous DNase I-hypersensitive sites and binding by the
multi-zinc finger protein CTCF (Xi et al. 2007). In contrast, the
Tal1 +18 region is characterized by a tissue-specific hypersensi-
tive site and not bound by CTCF (see Supplemental Fig. 5). More-
over, within our single-copy Hprt targeting constructs, the +18
region is located between the SV promoter and the Tal1 +19
enhancer and therefore not in the right position to protect the
+19 enhancer from encroaching inhibitory chromatin. We also
demonstrate that MIR elements are commonly found in the vi-
cinity of DNase I-hypersensitive sites, raising the possibility of a
more widespread regulatory role for this family of repeats. The
precise mechanism whereby the +18 element boosts the activity
of an associated enhancer remains unclear. Nevertheless, it is
clear from the data presented here that we have defined a novel
role for transposon-derived DNA sequence and thus added to the
growing list of possible functions of repetitive DNA, which until
fairly recently was considered to be “junk” DNA.
Regulatory variation is fundamental to evolution, and trans-
posable repeat sequences (which make up at least 50% of the
human genome; Kazazian 2004) may make a significant contri-
bution (Britten and Davidson 1971). With the advent of whole
genome sequencing projects and the availability of comprehen-
sive EST data sets, it has indeed been possible to verify that up to
25% of genes incorporate transposable elements into their pro-
moters and/or untranslated regions (Jordan et al. 2003; van de
Lagemaat et al. 2003). Moreover, in the few cases studied in de-
tail, transposable element-derived DNA was found to play a func-
tional role in promoter activity (Landry et al. 2002; Dunn et al.
2003). Promoters only represent a relatively small proportion of
active gene regulatory elements as evidenced by a recent ge-
nome-wide survey of DNase I-hypersensitive sites, which dem-
onstrate that only 16%–21% of DNase I-hypersensitive sites were
found in promoters or first exons of known genes (Boyle et al.
2008). The vast majority of gene regulatory activity therefore
appears to reside in distal regulatory elements. However, very
little is known about a possible role for transposable elements in
the evolution of distal regulatory elements, a situation most
likely explained by the relative ease of identifying promoters com-
pared to distal regulatory elements. Despite this, a few examples of
repetitive DNA gaining specific functions as distal regulatory el-
ements have emerged where transposable elements have been
shown to act as enhancers (Hambor et al. 1993; Bejerano et al.
2006; Santangelo et al. 2007) and silencers (Donnelly et al. 1999).
Indeed, a recent report suggests that many exapted nonexonic
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elements may be preferentially involved in distal cis-regulation
(Lowe et al. 2007)
Given the recent reports that 16% of eutherian-specific con-
served noncoding sequence is derived from transposable ele-
ments (Mikkelsen et al. 2007) and that a proportion of these
exapted noncoding elements are under strong purifying selection
(Lowe et al. 2007), it is becoming increasingly clear that repeti-
tive elements have been a driving force in carving the landscape
of the human genome. Here we describe a novel function,
whereby a repeat-derived sequence that would generally have
been discounted in many of the techniques used to delineate
gene regulatory pathways has become domesticated and acts to
boost the activity of an adjacent tissue-specific enhancer.
Methods
Preparation of DNase I-treated template, chromatin
immunoprecipitation, and real-time PCR analysis
DNase I-digested material was prepared from the 416B cell line as
previously described (Follows et al. 2006, 2007). ChIP assays were
performed as previously described (Landry et al. 2005). Briefly
416B cells were treated with 0.4% formaldehyde and the cross-
linked chromatin was retrieved by nuclei isolation and lysis. The
chromatin was sonicated to yield an average fragment size of
∼300 bp and immunoprecipitated with anti-GATA2 (sc-9008x,
Santa Cruz) to recover DNA-bound transcription factors and an
anti-acetyl H3K9 antibody (06-599, Upstate Biotechnology) to
recover acetylated histones. Enrichment was measured by real-
time PCR using Sybr green (Stratagene). The levels of enrichment
were normalized to those obtained with a control rabbit antibody
and were calculated as a fold increase over that measured at a
control region. The Tal1 +20 region was used as a control for both
the enrichment of GATA2 and acetyl H3K9. The following pairs
of primers were used: 17PW1f: CCGAG-GATTCTGATCACTCC;
17PW1r: GGCACTTTTCTTCCCTTGTG; 18PW1f: AGGAAGG
ACAGT-TGGTGTGG; 18PW1R: CTCAAAGTCACAAGCCAGCA;
19PW1f: GCAAGGTTGGGAGGTAT-CTG; 19PW1R: GAGCTG
GAAGGCAAAGTGAG; 20PW1f: AAGAATGGGATGTGCTTTGG;
20PW1R: GCAGCTGTTCTCCACTACGG.
Restriction endonuclease accessibility assay and transgenic
mouse analysis
416B cells were maintained as described previously (Bockamp et
al. 1997). The restriction endonuclease assay was performed as
described (Gottgens et al. 2001) using PalI digestion and a 210-bp
HindIII/StuI fragment ∼2 kb 3 of exon 6 as a probe. Transgenic
lacZ reporter constructs were driven by the 3.8-kb 0.9E3 fragment
of Tal1 (Sanchez et al. 1999; Sinclair et al. 1999) or the SV40
minimal promoter. DNA was linearized using BamHI and SalI,
and F0 transgenic embryos were generated by pronuclear injec-
tion as described (Sanchez et al. 1999). Embryos were harvested
at mid-gestation (embryonic day 11–12.5) and analyzed as de-
scribed (Sanchez et al. 1999).
Reporter constructs and transfection assays
Reporter constructs were generated by cloning the following
fragments of the Tal1 locus (numbering refers to the Tal1 locus
database entry AJ131017) downstream from the luciferase gene
in pGL2 (Promega) or downstream from an SV40 minimal pro-
moter containing a lacZ reporter cassette. The +18/+19 regions of
Tal1 were cloned as a 1.1-kb NcoI/HindIII fragment from 78,359
to 79,480 and an SspI site in the middle of this region was used
to generate the shorter 480-bp NcoI/SspI fragment from 78,359
to 78,840 and the 640-bp SspI/HindIII fragment from 78,840 to
79,480 for the +18 and +19 constructs, respectively. The muta-
tion constructs were made as previously described (Gottgens et
al. 2002b) and verified by sequencing. Stable transfections and
luciferase assays were performed as described (Gottgens et al.
1997). Data are presented as a representative plot of three bio-
logical replicates performed in quadruplicate plus/minus stan-
dard deviation unless otherwise stated.
ES cell culture and targeting
The HM-1 ES cell line was a kind gift from David Melton (Magin
et al. 1992). ES cells were cultured on mitotically inactivated
primary embryonic fibroblasts in standard ES cell media supple-
mented with LIF. For the introduction of transgenes at the Hprt
locus ∼1  108 ES cells were electroporated with 100 µg of Pme I
linearized DNA (0.8Kv,3uF Gene Pulser, Bio-Rad) followed by se-
lection in HAT media (Sigma). HAT-resistant colonies were
picked after 7–10-d growth in HAT-containing media. Targeted
ES cells were differentiated in 90-mm petri dishes in IMDM
supplemented with 15% FCS, 2 mM L-glutamine, 300 µg/mL
transferrin, 4  104 M MTG, 50 µg/mL ascorbic acid, and 5%
PFHM-II. Harvested EBs were either fixed and stained for 2 h with
X-gal as for the transgenic embryos or disrupted with trypsin for
3 min, and 1  106 cells lysed and assayed for lacZ activity using
the synthetic -galactosidase substrate ONPG as described
(Bockamp et al. 1995).
In vivo DMS footprinting
Footprinting was performed as previously described (Follows et
al. 2003). Briefly cells or genomic DNA were incubated at room
temperature in 0.2% DMS solution in PBS for 5 min. The reaction
was stopped with multiple washes with ice-cold PBS. Following
cell lysis and DNA extraction, DNA was cleaved with 0.1 M pi-
peridine at 90°C for 10 min and analyzed by ligation-mediated
PCR. PCR products were labeled by primer extension using 32P-
labeled nested primers and analyzed on 6% denaturing poly-
acrylamide gels. Linker and primer sequences are available on
request. Experiments were performed on three separate occasions
with material from two independent DMS-treated cell and geno-
mic DNA preparations.
Comparison of MIR repeats with genomic annotation
Five sets of genome annotation corresponding to the human
genome (NCBI v35/hg17/May 2004) were obtained for this
study, including a genome-wide set of coordinates for MIR family
repeats to be compared against four other data sets, namely: two
collections of DNase I-hypersensitive sites, histone methylation
sites, and random genomic regions. All MIR family repeats were
obtained using the UCSC genome table browser (http://
genome.ucsc.edu). Genome coordinates were output in the BED
format, selecting the group: “Variation and Repeats”, track: “Re-
peatMasker”, and table: “rmsk” (n = 591,703). Two sets of DNase
I hypersensitivity site annotation were extracted using the table
browser. The first ENCODE-based set, by Sabo et al. (2004), was
retrieved by selecting the group: “ENCODE Chromosome, Chro-
matin and DNA Structure”, track: “UW Dnase-array”, and table:
“DNase I HSs” (n = 2768). The second genome-wide set, by Boyle
et al. (2008), was retrieved by selecting the group: “Expression
and Regulation”, track: “Duke DNase Sites”, and table:
Evolution of a stem cell enhancer
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“dukeDnaseCd4Sites” (n = 95,723). Histone methylation sites
were extracted from the supplementary Web site relating to the
work of Barski et al. (2007). “Summary BED files” for H3K4me1,
H3K4me3, and H3K27me3 modifications were downloaded. A
Perl script was used to convert the files from “variable step” to
BED format and extract all regions containing a minimum num-
ber of tags, resulting in the most significant ∼2000 regions per
histone modification. The minimum numbers of tags for
H3K4me1, H3K4me3, and H3K27me3 modifications represented
in the extracted data where 42, 87, and 9 respectively. The ge-
nome coordinates were converted from human version hg18 to
hg17 using the “liftOver” conversion function of Galaxy (Giar-
dine et al. 2005; http://g2.trac.bx.psu.edu/).
To allow the calculation of Z-scores (to evaluate the chance
of randomly finding an overlap between the ENCODE DNase
I-hypersensitive sites and MIR repeats), 1000 sets of 2768 random
genome coordinates, each of 250 nucleotides in length, were
generated using a Perl script. A second Perl script was used to
calculate the percentage overlap of each random genome coor-
dinate set (extended by 500 flanking nucleotides each side, cre-
ating a set of extended coordinates) with the MIR repeat coordi-
nates. The mean and standard deviation of the percentage over-
laps for the 1000 comparisons were then calculated.
The comparison of the MIR repeat coordinates to the other
data sets was performed using Galaxy. The coordinates of the two
collections of DNase I-hypersensitive sites and histone methyla-
tion sites were extended by 500 flanking nucleotides each side,
creating two sets of extended coordinates. The “intersection” (by
at least one nucleotide) between the extended coordinates and
the MIR family coordinates was determined.
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